×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
PMDA Town Hall
Session Chair(s)
Toshiyoshi Tominaga, PhD
Project Professor
Keio University Hospital, Japan
Representatives from PMDA will explain the progress of its third Five-Year Mid-Term plan, including the future initiative/challenges for faster review and better life cycle management of drugs. The audience will be provided an opportunity to ask questions to the panel.
Learning Objective : Recognize the latest progress of PMDA and Japanese regulation; Discuss with PMDA senior officials Japanese regulatory issues.
Speaker(s)
New Regulation in Japan and Future Direction of PMDA
Tatsuya Kondo, MD, PhD
SH Medical Excellence JAPAN, Japan
President
Science-based Initiatives of PMDA
Takao Yamori
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Executive Director
New Streams of Risk Management
Tomiko Tawaragi
RAD-AR, Japan
Chief Director
PMD Act and SAKIGAKE Strategy
Nobumasa Nakashima
Cabinet Office, Japan
Health Policy Director, National Healthcare Policy Secretariat
Have an account?
Ways to register
Registration override should work.